Download PDF
Thorac Cardiovasc Surg 2007; 55(07): 418-423
DOI: 10.1055/s-2007-965302
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Prevention of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery Using a Potassium-Magnesium-Aspartate Solution (Inzolen®)

S. N. Piper
1   Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen, Germany
,
A.-H. Kiessling
2   Department of Cardiac Surgery, Klinikum Ludwigshafen, Ludwigshafen, Germany
,
S. W. Suttner
1   Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen, Germany
,
M. Ducke
1   Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen, Germany
,
J. Boldt
1   Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen, Germany
,
K. D. Röhm
1   Department of Anaesthesiology and Intensive Care Medicine, Klinikum Ludwigshafen, Ludwigshafen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
28 September 2007 (online)

    Permissions and Reprints All articles of this category

Retraction notice

Following a review by Landesärztekammer Rheinland-Pfalz, the State Medical Association of Rheinland-Pfalz, it has been determined that there was no IRB approval for the study: Prevention of atrial fibrillation after coronary artery bypass graft surgery using a potassium-magnesium-aspartate solution (Inzolen). Thorac Cardiovasc Surg 2007;55:418-423.

For these reasons, The Thoracic and Cardiovascular Surgeon hereby gives notice that the paper shall be retracted in accordance with COPE guidelines.